Characteristics of IDH-mutant gliomas with non-canonical IDH mutation
- 17 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 151 (2), 279-286
- https://doi.org/10.1007/s11060-020-03662-x
Abstract
Background Approximately 10% of IDH-mutant gliomas harbour non-canonical IDH mutations (non-p.R132H IDH1 and IDH2 mutations). Objective The aim of this study was to analyse the characteristics of non-canonical IDH-mutant gliomas. Materials and methods We retrospectively analysed the characteristics of 166 patients with non-canonical IDH mutant gliomas and compared them to those of 155 consecutive patients with IDH1 p.R132H mutant gliomas. Results The median age at diagnosis was 38 years in patients with non-canonical IDH mutant gliomas and 43 years in glioma patients with IDH1 p.R132H-mutant tumours. Family history of cancer was more frequent among glioma patients harbouring non-canonical IDH mutations than in patients with IDH1 p.R132H mutations (22.2% vs 5.1%; P < 0.05). Tumours were predominantly localised in the frontal lobe regardless of the type of IDH mutation. Compared to IDH1 p.R132H-mutant gliomas, tumours with non-canonical IDH mutations were more frequently found in the infratentorial region (5.5% vs 0%; P < 0.05) and were often multicentric (4.8% vs 0.9%; P < 0.05). Compared to IDH1 P.R132H-mutant gliomas, tumours with non-canonical IDH1 mutations were more frequently astrocytomas (65.6% vs 43%, P < 0.05), while those with IDH2 mutations were more frequently oligodendrogliomas (85% vs 48.3%; P < 0.05). The median overall survival was similar in patients with IDH1 p.R132H-mutant gliomas and patients with non-canonical IDH-mutant gliomas. Conclusion Gliomas with non-canonical IDH mutations have distinct radiological and histological characteristics. The presence of such tumours seems to be associated with genetic predisposition to cancer development.Keywords
This publication has 21 references indexed in Scilit:
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- Characteristics of gliomas in patients with somatic IDH mosaicismActa Neuropathologica Communications, 2016
- Glioma Groups Based on 1p/19q,IDH, andTERTPromoter Mutations in TumorsThe New England Journal of Medicine, 2015
- A case of radiologically multicentric but genetically identical multiple glioblastomasBrain Tumor Pathology, 2013
- A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutationNature Genetics, 2012
- Inherited predisposition to gliomaNeuro-Oncology, 2009
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasActa Neuropathologica, 2009
- Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndromeActa Neuropathologica, 2009
- IDH1andIDH2Mutations in GliomasThe New England Journal of Medicine, 2009
- Les gliomes multiples : étude clinique et hypothèses physiopathologiquesRevue Neurologique, 2006